Shifting the paradigm: Early identification of colorectal cancer with C the Signs clinical decision support. Survival benefits of asymptomatic primary tumor resection after bevacizumab plus FOLFIRI as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results